Literature DB >> 31387808

Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation.

Sheng Xin1, Kai Huang2, Xin-Gen Zhu3.   

Abstract

GBM (glioblastoma multiforme) is the most malignant form of glioma and is the most commonly occurring primary malignant brain tumour. GBM is difficult to completely excise, resulting in an extremely high recurrence rate. The occurrence of an aggressive glioma phenotype depends on EMT (epithelial-mesenchymal transformation), in which epithelial cells transform into mesenchymal cells by losing their cell-cell adhesion and polarity. NcRNAs (non-coding RNAs) play a significant role in the cellular progression from a normal phenotype to a cancerous phenotype. Recently, many studies have shown that there are two essential regulatory ncRNAs, miRNAs (microRNAs) and lncRNAs, which are closely related to EMT. In this review, we conducted a comprehensive investigation of the dysregulated lncRNAs and miRNAs in gliomas with particular attention to the function and regulatory mechanisms of several important lncRNAs and miRNAs, and we discussed their roles as glioma diagnostic and prognostic biomarkers and their potential clinical applications as therapeutic targets.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Biomarker; EMT; Glioma; lncRNA (long non-coding RNA); miRNA (microRNA)

Mesh:

Substances:

Year:  2019        PMID: 31387808     DOI: 10.1016/j.prp.2019.152539

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  14 in total

1.  Up-regulation of LINC00665 contributes to the progression of glioma and correlates with its MRI characteristics.

Authors:  Wangsheng Chen; Lan Hong; Changlong Hou; Genlin Zong; Jianhua Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma.

Authors:  Jianjiao Wang; Shuguang Yang; Qiongyu Ji; Qingsong Li; Fenggang Zhou; Yang Li; Fei Yuan; Jie Liu; Yu Tian; Yan Zhao; Yongri Zheng
Journal:  Mol Ther Oncolytics       Date:  2020-03-30       Impact factor: 7.200

3.  miR-6869-5p Inhibits Glioma Cell Proliferation and Invasion via Targeting PGK1.

Authors:  Fakai Wang; Huanjun Zhang; Bing Liu; Wei Liu; Zengchao Zhang
Journal:  Mediators Inflamm       Date:  2020-05-21       Impact factor: 4.711

4.  Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.

Authors:  Lei Wang; Yan Liu; Zhengtao Yu; Jianwu Gong; Zhiyong Deng; Nianjun Ren; Zhe Zhong; Hao Cai; Zhi Tang; Haofeng Cheng; Shuai Chen; Zhengwen He
Journal:  J Transl Med       Date:  2021-05-17       Impact factor: 5.531

5.  Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.

Authors:  Christopher Dardis; David Donner; Nader Sanai; Joanne Xiu; Sandeep Mittal; Sharon K Michelhaugh; Manjari Pandey; Santosh Kesari; Amy B Heimberger; Zoran Gatalica; Michael W Korn; Ashley L Sumrall; Surasak Phuphanich
Journal:  BMC Neurol       Date:  2021-06-23       Impact factor: 2.474

Review 6.  The role of cigarette smoke-induced epigenetic alterations in inflammation.

Authors:  Dandan Zong; Xiangming Liu; Jinhua Li; Ruoyun Ouyang; Ping Chen
Journal:  Epigenetics Chromatin       Date:  2019-11-11       Impact factor: 4.954

7.  LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes.

Authors:  Zongze He; Juan Long; Chen Yang; Bo Gong; Meixiong Cheng; Qi Wang; Jian Tang
Journal:  Aging (Albany NY)       Date:  2020-10-21       Impact factor: 5.682

Review 8.  Non-coding RNAs in Brain Tumors, the Contribution of lncRNAs, circRNAs, and snoRNAs to Cancer Development-Their Diagnostic and Therapeutic Potential.

Authors:  Julia Latowska; Adriana Grabowska; Żaneta Zarębska; Konrad Kuczyński; Bogna Kuczyńska; Katarzyna Rolle
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

9.  MicroRNA‑422a functions as a tumor suppressor in glioma by regulating the Wnt/β‑catenin signaling pathway via RPN2.

Authors:  Jikui Sun; Zhijuan Chen; Jinbiao Xiong; Qiong Wang; Fan Tang; Xuebin Zhang; Lidong Mo; Chen Wang; Weijia Fan; Jinhuan Wang
Journal:  Oncol Rep       Date:  2020-08-19       Impact factor: 3.906

10.  lncRNA KCNQ1OT1 promotes proliferation and invasion of glioma cells by targeting the miR‑375/YAP pathway.

Authors:  Panfeng Ding; Bo Liang; Jixin Shou; Xinjun Wang
Journal:  Int J Mol Med       Date:  2020-10-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.